These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 8454844)

  • 41. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
    Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
    J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MHC-unrestricted transfer of antilisterial immunity by freshly isolated immune CD8 spleen cells.
    Lukacs K; Kurlander RJ
    J Immunol; 1989 Dec; 143(11):3731-6. PubMed ID: 2479688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins.
    Breloer M; Fleischer B; von Bonin A
    J Immunol; 1999 Mar; 162(6):3141-7. PubMed ID: 10092763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD3-negative lymphokine-activated cytotoxic cells express the CD3 epsilon gene.
    Biassoni R; Ferrini S; Prigione I; Moretta A; Long EO
    J Immunol; 1988 Mar; 140(5):1685-9. PubMed ID: 2894394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity.
    Müllbacher A; Hill AB; Blanden RV; Cowden WB; King NJ; Hla RT
    J Immunol; 1991 Sep; 147(6):1765-72. PubMed ID: 1890303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida albicans-specific Ly-2+ lymphocytes with cytolytic activity.
    Romani L; Mocci S; Cenci E; Rossi R; Puccetti P; Bistoni F
    Eur J Immunol; 1991 Jun; 21(6):1567-70. PubMed ID: 1828430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides.
    Heath WR; Vitiello A; Sherman LA
    J Immunol; 1989 Sep; 143(5):1441-6. PubMed ID: 2474598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restricted blocking of cytotoxic T-cell function by anti-H-2K/D antibodies.
    O'Neill HC
    Immunology; 1988 Feb; 63(2):241-6. PubMed ID: 3258275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
    Hui KM; Sim T; Foo TT; Oei AA
    J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The diversity of T cell receptors specific for self MHC gene products.
    Siliciano RF; Brookmeyer R; Shin HS
    J Immunol; 1983 Apr; 130(4):1512-20. PubMed ID: 6187810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
    Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self peptide/MHC class I complexes have a negligible effect on the response of some CD8+ T cells to foreign antigen.
    Spörri R; Reis e Sousa C
    Eur J Immunol; 2002 Nov; 32(11):3161-70. PubMed ID: 12555661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of MHC-antigen complex formation on antigen-presenting cells.
    Roosnek E; Demotz S; Corradin G; Lanzavecchia A
    J Immunol; 1988 Jun; 140(12):4079-82. PubMed ID: 2453565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence implicating I region-restricted antigen presentation in alloantigen and nominal antigen recognition by a dual-reactive helper T lymphocyte clone.
    Ma DI; Wilde DB; Gajewski T; Dunn DE; Fitch FW
    J Immunol; 1984 Sep; 133(3):1101-10. PubMed ID: 6235280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity.
    Kaufmann SH; Rodewald HR; Hug E; De Libero G
    J Immunol; 1988 May; 140(9):3173-9. PubMed ID: 3129513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.